Hospital DOTS linkage in Indonesia: a model for DOTS expansion into government and private hospitals.
BACKGROUND
To accelerate DOTS expansion, the hospital sector and specialized chest clinics must be engaged.


OBJECTIVE
To develop a model for public-private partnership through DOTS expansion into public and private hospitals in Indonesia.


METHODS
Model development included gaining commitment from stakeholders, stepwise training of hospital staff, and developing unified networks for case management, patient referral, laboratory quality assurance, supervision and evaluation.


RESULTS
The number of notified tuberculosis (TB) cases (all forms and new smear-positive) increased dramatically from baseline. Together, hospitals and chest clinics accounted for a significant proportion of the total cases notified by the province (51% of total TB cases and 56% of new smear-positive cases in 2004). Compared to health centers and chest clinics, hospitals reported lower cure and success rates. Despite the option for referral to health centers, the majority of patients diagnosed in hospitals and chest clinics in 2002-2004 opted to be fully managed by the diagnosing facility.


CONCLUSIONS
The roles and strengths of hospitals differ with regard to health centers, providing a rational basis for linkage of these health service components. In Yogyakarta, linkage became effective only after establishing a stakeholder-based provincial coordinating (DOTS) committee as the recognized interface between the National Tuberculosis Programme and various providers.
Irawati
S R
SR
Indonesian Hospital Association, Yogyakarta, Indonesia.
Basri
C
C
Arias
M S
MS
Prihatini
S
S
Rintiswati
N
N
Voskens
J
J
Kimerling
M E
ME
D000995:Antitubercular Agents / Q000627:therapeutic use*; D023801:Directly Observed Therapy; D016304:Hospitals, Private / Q000458:organization & administration*; D006779:Hospitals, Public / Q000458:organization & administration*; D006801:Humans; D007214:Indonesia / Q000453:epidemiology; D017146:Models, Organizational; D011785:Quality Assurance, Health Care; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
D000995:Antitubercular Agents